Monday, November 26, 2012

• Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patents from the Tuschl II Patent Estate Broadly Covering RNAi TherapeuticsBusiness Wire (Mon, Nov 26)

Wednesday, November 21, 2012

• Alnylam to Webcast Presentation at Upcoming Investor ConferencesBusiness Wire (Wed, Nov 21)

Monday, November 19, 2012

• Alnylam-Tekmira Settle UpZacks (Mon, Nov 19)
• Alnylam: Further Evidence That The Stock Is Overvaluedat Seeking Alpha (Mon, Nov 19)

Friday, November 16, 2012

• Alnylam Pharmaceuticals' CEO Discusses Restructuring of Relationship with Tekmira (Transcript)at Seeking Alpha (Fri, Nov 16)

Thursday, November 15, 2012

• Tekmira Could Offer Stockholders Huge Rewardsat Seeking Alpha (Thu, Nov 15)
• Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuationat Seeking Alpha (Thu, Nov 15)
• 7 Biotech Stocks Trading At Steep Discount To Target Priceat Seeking Alpha (Thu, Nov 15)

Wednesday, November 14, 2012

• Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Alpha-1 Antitrypsin (AAT) DeficiencyBusiness Wire (Wed, Nov 14)

Tuesday, November 13, 2012

• Alnylam Pharmaceuticals Management Presents at the Lazard Capital Markets Healthcare Conference (Transcript)at Seeking Alpha (Tue, Nov 13)
• Alnylam, Tekmira shares rise after deal announcedAP (Tue, Nov 13)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MateriEDGAR Online (Tue, Nov 13)

Monday, November 12, 2012

• Alnylam to Webcast Conference Call to Discuss Restructuring of Relationship with TekmiraBusiness Wire (Mon, Nov 12)
• Alnylam and Tekmira Restructure Relationship and Settle All LitigationBusiness Wire (Mon, Nov 12)

Wednesday, November 7, 2012

• Isis Misses on Both CountsZacks (Wed, Nov 7)
• Revenues Decline at AlnylamZacks (Wed, Nov 7)

Monday, November 5, 2012

• Alnylam's CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Mon, Nov 5)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Mon, Nov 5)
• Alnylam Pharmaceuticals Reports Third Quarter 2012 Financial ResultsBusiness Wire (Mon, Nov 5)

Tuesday, October 23, 2012

• BSD Medical Shares Pop, Isis Receives Payment From Alnylam: Healthcare Business Wrapat Wall St. Cheat Sheet (Tue, Oct 23)
• Isis Pharma gets $1.1M payment from AlnylamAP (Tue, Oct 23)

Monday, October 22, 2012

• Healthcare Business Update: Merck Pays Milestone to Ligand, Alnylam Partners with Genzymeat Wall St. Cheat Sheet (Mon, Oct 22)
• Alnylam and Genzyme Discuss Alliance to Develop and Commercialize RNAi Therapeutics in Asia (Transcript)at Seeking Alpha (Mon, Oct 22)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Mon, Oct 22)
• Alnylam and Genzyme ink orphan-disease deal for ATTR drugat bizjournals.com (Mon, Oct 22)

Add ALNY News to My Yahoo!